Skip to main content
. 2022 Sep 28;1(1):e000215. doi: 10.1136/bmjmed-2022-000215

Table 2.

Rates of death and diagnosis of chronic obstructive pulmonary disease (COPD) in base cohort

Death with underlying cause of COPD New diagnosis of COPD
Group with history of illicit opioid use
No of participants at baseline 106 789 104 358*
Median (IQR) follow-up per participant (years) 8.7 (4.3-13.5) 3.3 (1.3-7.2)
No of events (ie, death or COPD diagnosis) 680 4016
Rate (95% CI) of events per 100 000 person years 71 (66 to 76) 799 (774 to 824)
Comparison group (matched by age, sex, and general practice)
No of participants at baseline 320 367 318,999*
Median (IQR) years of follow-up per participant (years) 9.5 (5.0-14.4) 5.6 (2.5-10.4)
No of events 160 3051
Rate (95% CI) of events per 100 000 person years 5.6 (4.8 to 6.5) 153 (147 to 158)
Hazard ratio (95% CI)
Adjusted for age and sex only 14.59 (12.28 to 17.33) 5.89 (5.62 to 6.18)
Additionally adjusted for smoking status at cohort entry 8.81 (7.36 to 10.54) 3.29 (3.13 to 3.46)

IQR=interquartile range; CI=confidence interval.

*Excluding participants with a diagnosis of COPD before cohort entry (ie, excluding participants with prevalent COPD).